Table 1 |.
Variable | |
---|---|
Age at diagnosis (years), median (range) | 12 (0–27.5) |
Age at enrollment (years), median (range) | 13 (0.2–28.8) |
Sex, n (%) | |
Female | 151 (44) |
Male | 194 (56) |
Race, n (%) | |
White | 244 (71) |
Black or African-American | 25 (7) |
Asian | 14 (4) |
More than one race | 29 (8) |
Other | 33 (10) |
Ethnicity, n (%) | |
Hispanic or Latino | 32 (9) |
Non-Hispanic | 275 (80) |
Unknown | 38 (11) |
Cancer diagnosis, n (%) | |
Osteosarcoma | 64 (19) |
Rhabdomyosarcoma | 46 (13) |
Ewing sarcoma | 44 (13) |
Other sarcoma | 70 (20) |
Renal tumor | 29 (8) |
Neuroblastoma | 28 (8) |
Liver tumor | 13 (4) |
Carcinoma | 19 (6) |
Other | 32 (9) |
Sequencing method, n (%) | |
Targeted DNA NGS only | 269 (78) |
Targeted DNA NGS + RNA NGS | 32 (9) |
Targeted DNA NGS + whole transcriptome | 26 (8) |
Targeted DNA NGS + RNA NGS + whole transcriptome | 18 (5) |